Skip to main content
. 2004 Mar;90(3):336–340. doi: 10.1136/hrt.2003.018622

Figure 1 .

Figure 1

Evidence for the benefits of lipid lowering. Primary and secondary cholesterol lowering statin trials illustrating the percentage of patients with a coronary heart disease (CHD) event (cardiovascular death or non-fatal myocardial infarction) against the mean low density lipoprotein (LDL) cholesterol during the study in intervention and placebo groups. Adapted from LaRosa JC. Unresolved issues: unanswered questions. Eur Heart J 1999;1(suppl J):J18–23.